Rx (Prescription Medicine)
USD $ 120.00
Bdsure 11.25mg 注射液是一种含有活性成分Leuprolide Acetate的药物。它是一种合成的非apeptide类似物，模拟促性腺激素释放激素（GnRH）。Leuprolide acetate最初通过刺激垂体 gland（腺体）导致黄体生成素（LH）和卵泡刺激素（FSH）的激增。然而，经过连续给药后，它会抑制垂体腺的反应，从而显著降低性激素（男性中的睾酮和女性中的雌激素）的生产。这种激素抑制使其在治疗激素敏感性疾病方面具有效性。
Bdsure 11.25mg 注射液适用于多种激素依赖性疾病的治疗。在男性中，用于晚期前列腺癌的姑息治疗。在女性中，用于子宫内膜异位症和子宫肌瘤的治疗。它也可用于儿童的早发性性成熟。剂量和治疗时长由医生根据具体病情和患者反应确定。常见的不良反应可能包括潮热、性欲下降、勃起功能障碍以及注射部位反应。必须按照制造商的指示储存此药物，通常在室温下保存，并避免光照和潮湿。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength | |
| Brand Name | |
| Molecule | |
| Strength | 11.25 mg |
| Medicine Form | Injection |
| Pack Quantity | 1 Vial |
| Packaging Type | Vial / Bottle |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
其他品牌的 Leuprolide Acetate 11.25 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
